CMS proposes sweeping ACA exchange rule
The CMS said the regulation should remove barriers to more affordable health plans, like catastrophic coverage, as enrollment on the exchanges falls following the expiration of stronger financial assistance.
Uncategorized
4 takeaways from the 2026 AF Symposium
Johnson & Johnson, Boston Scientific and Abbott were among the companies showcasing new data on atrial fibrillation treatments, including pulsed field ablation catheters.
Baxter cuts roughly 90 jobs at IV solutions plant that recovered from Hurricane Helene
Baxter’s North Cove site made about 60% of the U.S. supply of IV fluids. Hospital demand for IV solutions in the U.S. is lower than before Hurricane Helene, the company said.
Baxter cuts roughly 90 jobs at IV solutions plant that recovered from Hurricane Helene Read More »
Baxter cuts roughly 90 jobs at IV solutions plant that recovered from Hurricane Helene
Hospital demand for IV solutions in the U.S. is lower than before Hurricane Helene, the company said.
Baxter cuts roughly 90 jobs at IV solutions plant that recovered from Hurricane Helene Read More »
Stryker starts limited release of Mako RPS handheld knee robot
Surgeons interested in robotic technology but wanting a simpler system than existing platforms are the target market for the new device.
Stryker starts limited release of Mako RPS handheld knee robot Read More »
Evommune Soars as Dermatitis Treatment Rivals Dupixent in Mid-Stage Trial
The newly public Evommune shared data showing that EVO301, an IL-18 targeting protein, cleared symptoms comparably to Regeneron and Sanofi’s mega-blockbuster in a mid-stage atopic dermatitis clinical trial.
Evommune Soars as Dermatitis Treatment Rivals Dupixent in Mid-Stage Trial Read More »
Probabilidad, percepción del riesgo y confianza del usuario en plataformas de casino online
La confianza no nace del marketing. Nace de la comprensión. En entornos donde el azar es estructural, como los casinos online, los usuarios no buscan certezas. Buscan coherencia. Buscan sistemas que puedan entender, aunque no puedan predecirlos. Desde la perspectiva cient&ia …
Hims & Hers’ Woes Compound as FDA Hits Company With Warning Letter
The agency flagged several violations at a compounding pharmacy owned by Hims & Hers, including “infestation by rodents, birds insects, and other vermin.”
Hims & Hers’ Woes Compound as FDA Hits Company With Warning Letter Read More »
AstraZeneca Teases ‘Very Competitive’ Weight-Loss Pill—But Stays Mum on Details
AstraZeneca will push the pill, elecoglipron, into a comprehensive late-stage program that will test the drug as a monotherapy, as part of a combination regimen and for several indications.
AstraZeneca Teases ‘Very Competitive’ Weight-Loss Pill—But Stays Mum on Details Read More »
REGENXBIO’s Hunter Syndrome Gene Therapy Fails to Win FDA Nod
The FDA recommended that REGENXBIO run a new study, treat more patients and include a placebo arm to support a resubmission for the gene therapy RGX-121.
REGENXBIO’s Hunter Syndrome Gene Therapy Fails to Win FDA Nod Read More »